Haemonetics (HAE) Other financing activities (2009 - 2026)

Haemonetics' Other financing activities history runs 16 years deep, the most recent figure standing at -$13000.0 for Q1 2026.

• In Q1 2026, Other financing activities rose 99.94% year-over-year to -$13000.0; the TTM figure through Mar 2026 stood at -$102000.0 (up 59.04% YoY), while the FY2026 annual figure was -$102000.0, up 59.04% from the prior year.
• Other financing activities was -$13000.0 for Q1 2026 at Haemonetics, up from -$14000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $23.1 million in Q2 2024 to a low of -$23.4 million in Q1 2025.
• Historically, Other financing activities has averaged -$12916.7 across 5 years, with a median of -$13000.0 in 2022.
• The sharpest annual moves came in 2023 and 2024: Other financing activities tumbled 6538.46% in 2023, then surged 2780.76% in 2024.
• A 5-year view of Other financing activities shows it stood at $1.1 million in 2022, then dropped by 23.93% to $868000.0 in 2023, then soared by 2565.32% to $23.1 million in 2024, then tumbled by 100.06% to -$14000.0 in 2025, then rose by 7.14% to -$13000.0 in 2026.
• The last three Other financing activities figures came in at -$13000.0 (Q1 2026), -$14000.0 (Q4 2025), and -$75000.0 (Q3 2025), per Business Quant data.